Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions

Oral macrocyclic peptides have the potential to offer biologic-like efficacy and safety in a convenient oral ...

VENU Joins Boston Common Golf as Official Partner

Venu Holding Corporation ("VENU" or the "Company") (NYSE American: VENU), the fan-founded, fan-owned, and artist-inspired ...